2020
DOI: 10.1021/acs.jmedchem.0c00853
|View full text |Cite
|
Sign up to set email alerts
|

Structure of Human Phosphodiesterase 5A1 Complexed with Avanafil Reveals Molecular Basis of Isoform Selectivity and Guidelines for Targeting α-Helix Backbone Oxygen by Halogen Bonding

Abstract: Phosphodiesterase 5A1 (PDE5) is a key target for treating cardiovascular diseases and erectile dysfunction. Here, we report the crystal structure of PDE5 complexed with the sole second generation drug avanafil. Analysis of protein–drug interactions revealed the structural basis of avanafil’s superior isoform selectivity. Moreover, a halogen bonding was observed between avanafil and a backbone carbonyl oxygen of an adjacent α-helix, whose contribution to inhibitory potency illustrates the feasibility of exploit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 61 publications
1
13
0
Order By: Relevance
“…10B ). These kinds of movements have been observed previously in recent articles where the H-loop moves inward as a result of binding of sildenafil to the Q-pocket, 25 similar pattern was observed in case of Sa. The effect of ligand binding on protein shape (contraction/expansion) and structure was observed by calculating the radius of gyration ( R g ) of the protein over the trajectories.…”
Section: Resultssupporting
confidence: 86%
“…10B ). These kinds of movements have been observed previously in recent articles where the H-loop moves inward as a result of binding of sildenafil to the Q-pocket, 25 similar pattern was observed in case of Sa. The effect of ligand binding on protein shape (contraction/expansion) and structure was observed by calculating the radius of gyration ( R g ) of the protein over the trajectories.…”
Section: Resultssupporting
confidence: 86%
“…The catalytic domain of PDE5A (residues 535-862; GenBank accession number BC126233.1) was subcloned into the T7 promoter-driven expression vector pET21b with a 6 × His-tag at the C-terminus ( Hsieh et al, 2020 ). The recombinant plasmid was transformed into E. coli strain BL21 (DE3) and grown in an autoinducing medium ( Studier 2005 ) containing 50 μg/mL ampicillin at 37 C until OD600 = 0.6–0.7, then induced protein expression at 15°C for 40 h. The PDE5A protein was purified through the Ni-NTA column (Thermo Scientific) and further purified by the HiPrep™26/60 Sephacryl™-S-200HR column (GE Healthcare).…”
Section: Methodsmentioning
confidence: 99%
“…The reason behind this property is its unique structure which includes aryl halide (-Cl) rather than nucleotide (purine base-sugarphosphodiester bonds) forming backbone of earlier discovered first line drugs for ED. [24] In the recent study of Hsieh et al (2020) [25], the structure of PDE5-AVA complex was determined at 1.9 Å resolution. The PDE5 inhibitors are known to be act by competing with cGMP for binding to the active site.…”
Section: Mechanism Of Actionmentioning
confidence: 99%